Angiography is a medical imaging procedure used to visualize blood vessels (arteries and veins) inside the body. Angiography devices are used to diagnose and evaluate many diseases of blood vessels and related conditions, such as injuries, aneurysms (ballooning of a blood vessel), blockages (due to blood clots or plaques), stenosis (narrowing of a blood vessel), congenital (birth-related) heart abnormalities, disorganized blood vessels, and blood supply to tumors. Images captured trough angiography is called as angiograms.
The angiography devices market in this report is broadly segmented by technology, products, applications, procedures, indications, and end users. The market, by products, is segmented into angiography systems, catheters, guide-wires, balloons, contrast media, vascular closure devices, and accessories. The market by technology is segmented into X-ray, computed tomography, and magnetic resonance angiography. Based on applications the market is segmented as diagnostic and therapeutic.
Based on indication the market is segmented as known/suspected CAD, valvular heart disease, congenital heart disease, and congenital heart failure. Based on procedure, the market is segmented as coronary angiography, micro-angiography, neuro-vascular, peripheral angiography, post-mortem CT angiography, and other procedures (radiofrequency (RF) tumor ablation studies, other RF procedures). The angiography devices end-user market is divided into hospitals, diagnostic centers, and academic research laboratories.
The global angiography devices market is expected to grow at a CAGR of 4.4% during the forecast period of 2014 to 2019. The increasing utilization of angiography procedures for the diagnosis and treatment of cardiovascular diseases owing to rise in the global population with cardiovascular diseases and heavy investments by medical imaging device manufacturers to offer advanced and innovative products for better results has propelled the growth of this market.
While developed regions like North America and Europe will show a sluggish growth, emerging markets like Asia and Rest of the World (Latin America) are expected to record strong growth. Countries like India, China, and Brazil will majorly drive the growth of these emerging markets owing to rising investment by public & private players in these countries, large patient population, and focus of leading players to capture growth opportunities in these markets.
Some prominent players in this market include Siemens Healthcare (Germany), GE Healthcare (U.K.), Toshiba Medical Systems Corporation (Japan), Shimadzu Corporation (Japan), Royal Philips Electronics (Netherlands), St. Jude Medical, Inc. (U.S.), Abbott Vascular (Abbott Laboratories) (U.S.), Cordis Corporation (A JNJ Company) (U.S.), Boston Scientific Corporation (U.S.), and Medtronic, Inc. (U.S.).
“
